Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Canopy Growth Corp. describes new cannabinoid CB1/CB2 receptor modulators

April 26, 2021

Zenith agrees with Astellas to study ZEN-3694 with enzalutamide in metastatic CRPC

April 23, 2021

ICAM-1 orchestrates radiotherapy abscopal effect

April 23, 2021

Tolremo Therapeutics describes new DYRK1B inhibitors

April 23, 2021

Shanghai Litedd identifies new ROR-gammaT agonists

April 23, 2021

Chinese investigators disclose HGFR and/or SRC and/or CSF1R inhibitors

April 23, 2021

Monopteros initiates phase I/Ib study of MPT-0118 in solid tumors

April 23, 2021

First patient dosed in investigator-initiated study of rigosertib in RDEB-associated SCC

April 23, 2021

Studies reveal activity, mechanism of TAM kinase inhibitor PF-5807

April 23, 2021

Boragen identifies new JAK inhibitors

April 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...